In fact, forced PRDM2a expression in chronic myelogenous leukemia-blast crisis (CML-BC) cell lines decreases activation of IGF-1 receptor and of the downstream signaling components ERK 1/2 and AKT. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.